nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Day 14 Endpoint for Acute GVHD Clinical Trials
|
Spyrou, Nikolaos |
|
|
|
4 |
p. 421-432 |
artikel |
2 |
Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria
|
Du, Yali |
|
|
|
4 |
p. 301-307 |
artikel |
3 |
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source
|
Sterling, Cole H. |
|
|
|
4 |
p. 267.e1-267.e5 |
artikel |
4 |
Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adult Patients with Acute Myeloid Leukemia
|
Mizuno, Shohei |
|
|
|
4 |
p. 314.e1-314.e10 |
artikel |
5 |
Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children
|
Klimentova, Maria |
|
|
|
4 |
p. 437.e1-437.e11 |
artikel |
6 |
American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients
|
Neofytos, Dionysios |
|
|
|
4 |
p. 222-227 |
artikel |
7 |
A More MAGICal Alogrithm in Acute GVHD
|
Hong, Sanghee |
|
|
|
4 |
p. 347-348 |
artikel |
8 |
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
|
Tokaz, Molly C. |
|
|
|
4 |
p. 279.e1-279.e10 |
artikel |
9 |
A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis
|
Kim, Haryoon |
|
|
|
4 |
p. 419.e1-419.e12 |
artikel |
10 |
An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation
|
Jeurkar, Chetan |
|
|
|
4 |
p. 327.e1-327.e11 |
artikel |
11 |
An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT
|
Haynes, Andrew S. |
|
|
|
4 |
p. 317-326 |
artikel |
12 |
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
|
Huang, Alice |
|
|
|
4 |
p. 214.e1-214.e11 |
artikel |
13 |
A Positive Psychology Intervention for Caregivers of Hematopoietic Stem Cell Transplantation Survivors (PATH-C): Initial Testing and Single-Arm Pilot Trial
|
Amonoo, Hermioni L. |
|
|
|
4 |
p. 448.e1-448.e14 |
artikel |
14 |
A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
|
Zhang, Ao-Bei |
|
|
|
4 |
p. 240.e1-240.e10 |
artikel |
15 |
A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)
|
Mupfudze, Tatenda G. |
|
|
|
4 |
p. 345-351 |
artikel |
16 |
Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation
|
Bognàr, Tim |
|
|
|
4 |
p. 196-202 |
artikel |
17 |
ASTCT Notes
|
|
|
|
|
4 |
p. 219 |
artikel |
18 |
ASTCT Notes
|
|
|
|
|
4 |
p. 353 |
artikel |
19 |
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience
|
Pasvolsky, Oren |
|
|
|
4 |
p. 260.e1-260.e6 |
artikel |
20 |
Body Weight Loss Before Allogeneic Hematopoietic Stem Cell Transplantation Predicts Survival Outcomes in Acute Leukemia Patients
|
Tamaki, Masaharu |
|
|
|
4 |
p. 340.e1-340.e6 |
artikel |
21 |
Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy
|
Hubbeling, Harper |
|
|
|
4 |
p. 259.e1-259.e10 |
artikel |
22 |
Building a Transplant Center: From the Karolinska to Kathmandu
|
Ringden, Olle |
|
|
|
4 |
p. 339-343 |
artikel |
23 |
Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant Disorders
|
Galvin, Robert T. |
|
|
|
4 |
p. 316.e1-316.e8 |
artikel |
24 |
Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival
|
Vigorito, Afonso Celso |
|
|
|
4 |
p. 276.e1-276.e7 |
artikel |
25 |
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model
|
Nakamura, Naokazu |
|
|
|
4 |
p. 404-414 |
artikel |
26 |
Commentary: Is Immune Recovery-Based Post-Transplantation Vaccination in Children Better Than Time-Based Revaccination?
|
Carpenter, Paul A. |
|
|
|
4 |
p. 281-283 |
artikel |
27 |
Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
|
Dhawale, Tejaswini |
|
|
|
4 |
p. 402.e1-402.e12 |
artikel |
28 |
Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
|
Hong, Sanghee |
|
|
|
4 |
p. 217.e1-217.e6 |
artikel |
29 |
Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy
|
Miyao, Kotaro |
|
|
|
4 |
p. 342.e1-342.e10 |
artikel |
30 |
Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion
|
Koster, Eva A.S. |
|
|
|
4 |
p. 268.e1-268.e10 |
artikel |
31 |
Cord Blood-Derived Multipotent Stem Cells Ameliorate in Vitro/in Vivo Alloreactive Responses, and This Effect Is Associated with Exosomal Microvesicles in Vitro
|
Descalzi-Montoya, Dante B. |
|
|
|
4 |
p. 396.e1-396.e14 |
artikel |
32 |
Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma
|
Hashmi, Hamza |
|
|
|
4 |
p. 262.e1-262.e6 |
artikel |
33 |
Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes
|
Rashid, Nahid |
|
|
|
4 |
p. 417.e1-417.e9 |
artikel |
34 |
Discharge Disposition Following Hematopoietic Cell Transplantation: Predicting the Need for Rehabilitation and Association with Survival
|
Wall, Sarah A. |
|
|
|
4 |
p. 337.e1-337.e7 |
artikel |
35 |
Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma
|
Merino, Aimee M. |
|
|
|
4 |
p. 310.e1-310.e6 |
artikel |
36 |
Early-Phase Peripheral Blood Eosinophilia Predicts Lower Overall and Non-Relapse Mortality After Single-Unit Cord Blood Transplantation
|
Konuma, Takaaki |
|
|
|
4 |
p. 336.e1-336.e9 |
artikel |
37 |
Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease Prophylaxis
|
Oshrine, Benjamin |
|
|
|
4 |
p. 203.e1-203.e7 |
artikel |
38 |
Editorial Board
|
|
|
|
|
4 |
p. A7 |
artikel |
39 |
Editorial Board
|
|
|
|
|
4 |
p. A5 |
artikel |
40 |
Editorial Board
|
|
|
|
|
4 |
p. A6 |
artikel |
41 |
Editorial Board
|
|
|
|
|
4 |
p. A10 |
artikel |
42 |
Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation
|
Liu, Yin |
|
|
|
4 |
p. 332.e1-332.e8 |
artikel |
43 |
Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials
|
Krishnamurti, Lakshmanan |
|
|
|
4 |
p. 217-221 |
artikel |
44 |
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia
|
Alsaggaf, Rotana |
|
|
|
4 |
p. 313.e1-313.e8 |
artikel |
45 |
Ethical Challenges in CAR-T slot allocation
|
Faiman, Beth |
|
|
|
4 |
p. 215-216 |
artikel |
46 |
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience
|
Kourelis, Taxiarchis |
|
|
|
4 |
p. 255-258 |
artikel |
47 |
Factors Affecting Day-to-Day Variations in Tacrolimus Concentration among Children and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
Maruyama, Yuta |
|
|
|
4 |
p. 270.e1-270.e8 |
artikel |
48 |
Family-Focused Facilitated Fitness: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Their Caregiving Partners
|
Langer, Shelby L. |
|
|
|
4 |
p. 450.e1-450.e17 |
artikel |
49 |
Gaps in Medicaid Coverage and Financial Toxicity: A Health Disparity in Hematopoietic Cell Transplantation for Sickle Cell Disease
|
Krishnamurti, Lakshmanan |
|
|
|
4 |
p. 284-285 |
artikel |
50 |
Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect
|
Bernardi, Chiara |
|
|
|
4 |
p. 386-395 |
artikel |
51 |
Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia
|
Metheny, Leland |
|
|
|
4 |
p. 286-291 |
artikel |
52 |
Haploidentical Transplantation with Modified Post-transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience
|
Li, Yun |
|
|
|
4 |
p. 331.e1-331.e7 |
artikel |
53 |
High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation
|
Sumransub, Nuttavut |
|
|
|
4 |
p. 184.e1-184.e8 |
artikel |
54 |
Home-Based Hematopoietic Cell Transplantation in the United States
|
Sung, Anthony D. |
|
|
|
4 |
p. 207.e1-207.e8 |
artikel |
55 |
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis
|
Gabanti, Elisa |
|
|
|
4 |
p. 211.e1-211.e9 |
artikel |
56 |
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort
|
Glushkova, Svetlana |
|
|
|
4 |
p. 435.e1-435.e12 |
artikel |
57 |
Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults
|
Sugidono, Matthew |
|
|
|
4 |
p. 344.e1-344.e5 |
artikel |
58 |
Improved Accessibility of Optimally Matched Stem Cell Donors
|
Fleischhauer, Katharina |
|
|
|
4 |
p. 213-214 |
artikel |
59 |
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
|
Rotz, Seth J. |
|
|
|
4 |
p. 349-385 |
artikel |
60 |
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases
|
Cattoni, Alessandro |
|
|
|
4 |
p. 271.e1-271.e12 |
artikel |
61 |
Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study
|
Saglio, Francesco |
|
|
|
4 |
p. 433.e1-433.e10 |
artikel |
62 |
Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients
|
Einarsdottir, Sigrun |
|
|
|
4 |
p. 275.e1-275.e5 |
artikel |
63 |
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study
|
Rodríguez-Arbolí, Eduardo |
|
|
|
4 |
p. 311.e1-311.e10 |
artikel |
64 |
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
|
Afrough, Aimaz |
|
|
|
4 |
p. 264.e1-264.e9 |
artikel |
65 |
Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation
|
Kuwatsuka, Yachiyo |
|
|
|
4 |
p. 444.e1-444.e11 |
artikel |
66 |
Masthead (Purpose and Scope)
|
|
|
|
|
4 |
p. A6 |
artikel |
67 |
Masthead (Purpose and Scope)
|
|
|
|
|
4 |
p. A4 |
artikel |
68 |
Masthead (Purpose and Scope)
|
|
|
|
|
4 |
p. A5 |
artikel |
69 |
Masthead (Purpose and Scope)
|
|
|
|
|
4 |
p. A9 |
artikel |
70 |
Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model
|
Shi, Chunyu |
|
|
|
4 |
p. 398.e1-398.e10 |
artikel |
71 |
Mature Naive B Cells Regulate the Outcome of Murine Acute Graft-versus-Host Disease in an IL-10-Independent Manner
|
Galvani, Rômulo Gonçalves |
|
|
|
4 |
p. 181.e1-181.e9 |
artikel |
72 |
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation
|
Ruggeri, Loredana |
|
|
|
4 |
p. 206.e1-206.e6 |
artikel |
73 |
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas
|
Castagna, Luca |
|
|
|
4 |
p. 328.e1-328.e6 |
artikel |
74 |
Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T
|
Akinola, Idayat M. |
|
|
|
4 |
p. 254.e1-254.e9 |
artikel |
75 |
N-Acetyl-L-Cysteine Potentially Inhibits Complement Activation in Transplantation-Associated Thrombotic Microangiopathy
|
Qi, Jiaqian |
|
|
|
4 |
p. 216.e1-216.e5 |
artikel |
76 |
Non-Graft-versus-Host Disease Enterocolitis Following Cord Blood Transplantation is Real, with Poorly Understood Pathophysiology, and Requires Distinct Management, with Eventual Resolution without Immune Suppression
|
Horgan, Claire |
|
|
|
4 |
p. 440.e1-440.e9 |
artikel |
77 |
Officers and Directors of ASTCT
|
|
|
|
|
4 |
p. A8 |
artikel |
78 |
Officers and Directors of ASTCT
|
|
|
|
|
4 |
p. A6 |
artikel |
79 |
Officers and Directors of ASTCT
|
|
|
|
|
4 |
p. A7 |
artikel |
80 |
Officers and Directors of ASTCT
|
|
|
|
|
4 |
p. A11 |
artikel |
81 |
Optimal Timing of Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
|
Cipkar, Christopher |
|
|
|
4 |
p. 189-194 |
artikel |
82 |
Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics Matter
|
Ros-Soto, Jose |
|
|
|
4 |
p. 183.e1-183.e8 |
artikel |
83 |
Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
|
Mirza, Abu-Sayeef |
|
|
|
4 |
p. 185.e1-185.e7 |
artikel |
84 |
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy
|
Perl, Alexander E. |
|
|
|
4 |
p. 265.e1-265.e10 |
artikel |
85 |
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
|
Murthy, Hemant S. |
|
|
|
4 |
p. 187.e1-187.e10 |
artikel |
86 |
Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies
|
Nikiforow, Sarah |
|
|
|
4 |
p. 228-239 |
artikel |
87 |
Pediatric Hematopoietic Stem Cell Transplantation: Challenges in Small European Countries
|
Rascon, Jelena |
|
|
|
4 |
p. 269.e1-269.e10 |
artikel |
88 |
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types
|
Kaida, Katsuji |
|
|
|
4 |
p. 273.e1-273.e9 |
artikel |
89 |
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
|
Yoon, Dok Hyun |
|
|
|
4 |
p. 253.e1-253.e9 |
artikel |
90 |
Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study
|
Dovern, Elisabeth |
|
|
|
4 |
p. 283.e1-283.e9 |
artikel |
91 |
Picture Perfect Predictive Model: Does it Exist?
|
Sainatham, Chiranjeevi |
|
|
|
4 |
p. 344-346 |
artikel |
92 |
Plasma Levels of MRP-8/14 Associate With Neutrophil Recovery, Bacterial Bloodstream Infections, and Engraftment Syndrome Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
|
Kammersgaard, Marte B. |
|
|
|
4 |
p. 242.e1-242.e9 |
artikel |
93 |
Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy
|
Lee, Dasom |
|
|
|
4 |
p. 277.e1-277.e9 |
artikel |
94 |
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC
|
Bailén, Rebeca |
|
|
|
4 |
p. 204.e1-204.e10 |
artikel |
95 |
Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia
|
Hong, Kyung Taek |
|
|
|
4 |
p. 195.e1-195.e7 |
artikel |
96 |
Post-Traumatic Stress Symptoms in Hematopoietic Stem Cell Transplant Recipients
|
Fenech, Alyssa L. |
|
|
|
4 |
p. 341.e1-341.e6 |
artikel |
97 |
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients
|
Sung, Anthony D. |
|
|
|
4 |
p. 415.e1-415.e16 |
artikel |
98 |
Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio
|
Miyazaki, Takuya |
|
|
|
4 |
p. 400.e1-400.e9 |
artikel |
99 |
Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study
|
Li, Ang |
|
|
|
4 |
p. 308.e1-308.e8 |
artikel |
100 |
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
|
Parmar, Harsh |
|
|
|
4 |
p. 309.e1-309.e5 |
artikel |
101 |
Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy
|
Barata, Anna |
|
|
|
4 |
p. 452.e1-452.e11 |
artikel |
102 |
Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis
|
Puckrin, Robert |
|
|
|
4 |
p. 218.e1-218.e4 |
artikel |
103 |
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report
|
Bankova, Andriyana K. |
|
|
|
4 |
p. 215.e1-215.e10 |
artikel |
104 |
Reduced Cytokine Release Syndrome and Improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell Transplantation
|
Tang, Jerrica |
|
|
|
4 |
p. 438.e1-438.e11 |
artikel |
105 |
Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group
|
Kimura, Shun-ichi |
|
|
|
4 |
p. 209.e1-209.e9 |
artikel |
106 |
Risk of Cytomegalovirus Infection with Post-Transplantation Cyclophosphamide in Haploidentical and HLA-Matched Unrelated Donor Transplantation
|
Jamy, Omer |
|
|
|
4 |
p. 213.e1-213.e6 |
artikel |
107 |
Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation
|
Sumransub, Nuttavut |
|
|
|
4 |
p. 263.e1-263.e7 |
artikel |
108 |
Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy
|
Bansal, Radhika |
|
|
|
4 |
p. 455.e1-455.e7 |
artikel |
109 |
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
|
Seftel, Matthew D. |
|
|
|
4 |
p. 352.e1-352.e5 |
artikel |
110 |
Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell–Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia
|
Shelikhova, Larisa |
|
|
|
4 |
p. 330.e1-330.e9 |
artikel |
111 |
Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission
|
Konuma, Takaaki |
|
|
|
4 |
p. 334.e1-334.e11 |
artikel |
112 |
Sinusoidal Obstruction Syndrome in Critically Ill Patients in the Era of Defibrotide: A Retrospective Multicenter Study
|
Debureaux, Pierre-Edouard |
|
|
|
4 |
p. 338.e1-338.e7 |
artikel |
113 |
Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study
|
Bulthuis, Marjolein S. |
|
|
|
4 |
p. 446.e1-446.e11 |
artikel |
114 |
Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
|
Dandoy, Christopher E. |
|
|
|
4 |
p. 282.e1-282.e9 |
artikel |
115 |
Table of Contents
|
|
|
|
|
4 |
p. A17-A20 |
artikel |
116 |
Table of Contents
|
|
|
|
|
4 |
p. A7-A11 |
artikel |
117 |
Table of Contents
|
|
|
|
|
4 |
p. A8-A13 |
artikel |
118 |
Table of Contents
|
|
|
|
|
4 |
p. A12-A15 |
artikel |
119 |
TIMING IS EVERYTHING: When IS the Time Right for Transplant in Myelofibrosis Therapy?
|
Gowin, Krisstina |
|
|
|
4 |
p. 177-178 |
artikel |
120 |
Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients
|
Schwenk, Hayden T. |
|
|
|
4 |
p. 292-300 |
artikel |
121 |
Unrelated Stem Cell Donor HLA Match Likelihood in the US Registry Incorporating HLA-DPB1 Permissive Mismatching
|
Gragert, Loren |
|
|
|
4 |
p. 244-252 |
artikel |
122 |
Upfront Umbilical Cord Blood Transplantation Versus Immunosuppressive Therapy for Pediatric Patients With Idiopathic Severe Aplastic Anemia
|
Zhao, Xuxu |
|
|
|
4 |
p. 442.e1-442.e13 |
artikel |
123 |
Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults
|
Ramos, Kristie N. |
|
|
|
4 |
p. 454.e1-454.e6 |
artikel |
124 |
VOD/SOS and Alkylating Agents in the Hematopoietic Stem Cell Transplant Setting: New Insights and Further Questions
|
Myers, Alan L. |
|
|
|
4 |
p. 179-180 |
artikel |